Press release
Global Anti-infective Drugs Market Surges Past US$ 139 Billion in 2022, Poised for Continued Growth
Anti-infective Drugs
Request Your Sample Copy: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41204
Market Segmentation:
Drug Class
• Antibacterials
• B-lactams
• Quinolones
• Macrolides
• Tetracycline
• Aminoglycoside
• Others (Phenicols, Sulfonamides, etc.)
Antivirals
• Miscellaneous Antivirals
• Adamantane Antivirals
• Antiviral Boosters
• Others (Antiviral Combinations, Antiviral Interferons, etc.)
Antifungals
• Azoles
• Echinocandins
• Polyenes
• Others
• Others (Antiparasitics, Anthelmintics, etc.)
Route of Administration
• Oral
• Parenteral
• Others (Topical, etc.)
Indication
• Pneumonia
• Sepsis
• Tuberculosis
• Influenza
• HIV Infection
• Hepatitis Virus Infection
• Respiratory Virus Infection
• Others (Aspergillosis, Candidiasis, Dermatophytosis, etc.)
Companies Profiled:
Pfizer Inc., Gland Pharma Ltd., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Novartis AG, Gilead Sciences, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Abbott, Astellas Pharma Inc., Alkem Laboratories, AstraZeneca, Eli Lilly and Company, Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, and Sanofi
Market Drivers and Challenges
Several factors are driving the growth of the anti-infective drugs market. The rise in infectious diseases, increasing drug-resistant strains, and a growing global population contribute significantly. However, challenges such as regulatory hurdles, patent expirations, and the high cost of drug development pose obstacles for market players. Navigating these challenges requires a strategic approach to ensure sustained growth.
Latest Market Trends
In this rapidly evolving landscape, staying abreast of the latest trends is imperative for stakeholders. The market is witnessing a surge in collaborations and partnerships among pharmaceutical companies, aiming to enhance research and development capabilities. Additionally, the advent of personalized medicine and the use of advanced technologies like artificial intelligence in drug discovery are reshaping the industry.
Future Outlook and Market Opportunities
The future of the anti-infective drugs market appears promising, with increasing investments in research and development. Opportunities lie in the development of novel drugs, innovative treatment approaches, and addressing unmet medical needs. Market players need to capitalize on these opportunities to stay ahead in this competitive landscape.
Explore the TOC and stay ahead in the competitive anti-infective drugs market: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=41204
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact Us
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Anti-infective Drugs Market Surges Past US$ 139 Billion in 2022, Poised for Continued Growth here
News-ID: 3339999 • Views: …
More Releases from Transparency Market Research
Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 B …
The global gas compressor market was valued at US$ 23.2 Bn in 2025 and is projected to reach US$ 41.0 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. This steady growth trajectory reflects the structural importance of gas compression systems across upstream, midstream, and downstream gas value chains. Rising natural gas consumption, expansion of pipeline and LNG infrastructure, and national energy…
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Applicati …
The global anesthesia drugs market was valued at US$ 7.6 billion in 2025 and is projected to reach US$ 12.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2036. This steady growth trajectory reflects the essential and non-substitutable role of anesthesia drugs in modern healthcare systems. As surgical interventions continue to rise globally-across both elective and emergency procedures-the demand for safe, effective,…
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million t …
The global single-atom catalysts (SACs) market is poised for remarkable growth as industries seek highly efficient, cost-effective, and sustainable catalytic solutions. Valued at US$ 177.8 million in 2025, the market is projected to reach US$ 1,000.2 million by 2036, expanding at a robust compound annual growth rate (CAGR) of 17.0% from 2026 to 2036. This rapid expansion reflects the growing importance of advanced catalysis in energy, chemicals, environmental protection, and…
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported b …
The non-specific endonuclease market is witnessing steady growth, driven by the expanding use of molecular biology tools across biotechnology, pharmaceuticals, diagnostics, and academic research. Non-specific endonucleases are enzymes that cleave nucleic acids without requiring a specific recognition sequence, making them highly valuable for applications such as DNA/RNA degradation, sample preparation, viscosity reduction, and contamination control. Their broad activity profile differentiates them from restriction enzymes and enables versatile usage across multiple…
More Releases for Antiviral
Global Antiviral Therapeutics Market Size - By Product Type(Herpes Antiviral Dru …
Antiviral Therapeutics Market Insights: Trends, Drivers, and Outlook 2024 - 2031
Antiviral Therapeutics Market Scope: Unveiling Today's Trends
Antiviral therapeutics are medications designed to treat viral infections by inhibiting viral replication and mitigating symptoms. The Antiviral Therapeutics market is experiencing significant growth, driven by the increasing prevalence of viral diseases, ongoing research and development, and the ongoing impact of emerging viral outbreaks. Key trends include a rising focus on personalized medicine and…
Antiviral Drugs Market: Advancements in Antiviral Drugs - Analysis by Medical Ex …
Allied Market Research recently said Antiviral drugs have been at the forefront of medical advancements, offering effective treatment and prevention options against a wide range of viral infections. These pharmaceutical agents are specifically designed to target and inhibit the replication of viruses, helping to control the spread of viral diseases and improve patient outcomes. In recent years, significant progress has been made in the development of antiviral drugs, revolutionizing the…
Antiviral Drugs Market
“Antiviral Drugs Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.
This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market…
Antiviral therapies Market: High Cost of Antiviral therapies Is a Major Restrain …
Post COVID-19 Impact on Antiviral Therapies Market –With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues. Research Dive’ group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive…
Coronavirus's Impact On Antiviral Packaging Market
Antiviral Packaging Market – An Overview
The coronavirus pandemic keeps on revamping the idea of worldwide society in 2020, and with it changes the perspectives and practices of buyers now and for a long time to come. In any case, the prompt effect on buyers’ interests about viral introduction and questions hanging about the infection’s capacity to make due on surfaces, may fuel an any longer enduring interest for new bundling…
Magniflex Introduces Antiviral and Antibacterial Collection
Magniflex, the renowned mattress manufacturer from Italy, has always had innovation in its DNA, as the success, accolades, and certifications obtained over the years prove, and the goal has always been to introduce innovative solutions to common issues that affect the quality of our sleep. As a response to the COVID-19 global pandemic, Magniflex conducted scientific and technological research in collaboration with prominent experts in order to produce MagniProtect: an…
